Literature DB >> 26280849

Treatment of large diaphyseal bone defect of the tibia by the "fibula pro tibia" technique: application in developing countries.

René Castro Gayito, Giambattista Priuli, Sidi Yaya Traore, Olivier Barbier, Pierre-Louis Docquier.   

Abstract

Large segmental bone defects of the tibia may be due to infections, high-energy fractures, congenital diseases or tumors and represent a challenge for both the physician and the patient. In developing countries, the use of expansive techniques is not possible so that amputation is sometimes proposed. However, an alternative technique for limb salvage, applicable in developing countries consists of tibialization of the ipsilateral fibula. This technique is also called "Fibula pro Tibia", fibular transfer to the tibia or fibular centralization. We report this transfer in 4 patients with an average defect length of 11.8 cm. Union between the transferred fibula and the tibia was obtained in all patients, for both proximal and distal junctions, after an average time of 8.5 months (range, 4 to 18 months). Three patients returned to a normal walking function while one was still limping, but was able to walk independently without need of crutches.

Entities:  

Mesh:

Year:  2015        PMID: 26280849

Source DB:  PubMed          Journal:  Acta Orthop Belg        ISSN: 0001-6462            Impact factor:   0.500


  2 in total

1.  Decision-making algorithm for sequential treatment of diaphyseal bone gaps in war-wounded patients in the Middle East.

Authors:  Rasheed M Fakhri; Patrick Herard; Mohammed I Liswi; Anne L Boulart; Ali M K Al Ani
Journal:  Int Orthop       Date:  2019-02-23       Impact factor: 3.075

2.  Evaluation of the efficacy of ipsilateral fibular transfer for reconstruction of large tibial defects in children: a retrospective study.

Authors:  SiYu Xu; YaoXi Liu; GuangHui Zhu; Kun Liu; Jin Tang; JiangYan Wu; An Yan; Fei Jiang; ShaSha Mo; HaiBo Mei
Journal:  J Orthop Surg Res       Date:  2022-03-05       Impact factor: 2.359

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.